RE:Worth a read Wish I could get excited but I don't see this as being "SHRM" worthy. This is seems less like a breakthrough and more like a diversion or distraction. Go on line and see for yourself.
This is not why I bought into SHRM.
(n)SPRAVATO® (esketamine)* Nasal Spray is Available for Canadian Patients. TORONTO, July 22, 2020 /CNW/ - The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that SPRAVATO® (esketamine), following a Notice of Compliance (NOC) from Health Canada, is now available for Canadian patients.Jul 22, 2020
Esketamine, sold under the brand names Ketanest among others, is a medication used as a general anesthetic and for treatment-resistant depression. Esketamine is used as a nasal spray or by injection into a vein. Esketamine acts primarily as a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist.